ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Infectious Disease

Top Infectious Disease Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOSEPH GATHE M.D.

Infectious Disease

17,752

$8.42M

572
114 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

35%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 48%

$474
Average prescription price

Avg: $423

STEVEN KLEMOW M.D.

Infectious Disease

9,401

$3.76M

170
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

37%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 48%

$400
Average prescription price

Avg: $423

MAMTA JAIN MD MPH

Infectious Disease

9,219

$3.47M

395
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 48%

$377
Average prescription price

Avg: $423

CATHERINE COLQUITT M.D.

Infectious Disease

8,978

$3.28M

266
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 48%

$366
Average prescription price

Avg: $423

DICKSON ODERO MD

Infectious Disease

7,221

$1.4M

237
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 48%

$194
Average prescription price

Avg: $423

ANITA SCRIBNER MD

Infectious Disease

7,118

$3.15M

459
199 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 48%

$443
Average prescription price

Avg: $423

JAMES ZACHARY M.D.

Infectious Disease

6,590

$2.93M

226
14 are 65+

10%
patients receiving schedule two controlled substances

Avg: 0%

36%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 48%

$444
Average prescription price

Avg: $423

ELLEN KITCHELL MD

Infectious Disease

6,539

$2.68M

178
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

20%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 48%

$410
Average prescription price

Avg: $423

PENNY JAFFE MD

Infectious Disease

5,230

$2.76M

159
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 48%

$527
Average prescription price

Avg: $423

NATALIE VANEK MD

Infectious Disease

4,714

$1.98M

197
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 48%

$419
Average prescription price

Avg: $423

BEN BARNETT M.D.

Infectious Disease

4,556

$2.46M

191
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 48%

$540
Average prescription price

Avg: $423

KATIA BROWN M.D.

Infectious Disease

4,511

$1.72M

139
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

23%
patients receiving schedule three controlled substances

Avg: 8%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 48%

$381
Average prescription price

Avg: $423

ALLAN KELLY M.D.

Infectious Disease

4,214

$472K

199
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 48%

$112
Average prescription price

Avg: $423

ELIZABETH RAMOS-SALAZAR M.D.

Infectious Disease

4,040

$157K

253
199 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

17%
patients receiving schedule three controlled substances

Avg: 8%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 48%

$39
Average prescription price

Avg: $423

ROBERTO ANDRADE MD

Infectious Disease

3,401

$1.67M

121
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 48%

$490
Average prescription price

Avg: $423

JOSE SERPA-ALVAREZ MD

Infectious Disease

3,070

$1.35M

135
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 48%

$439
Average prescription price

Avg: $423

RASHA GHURANI MD

Infectious Disease

3,031

$1.36M

131
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

18%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 48%

$448
Average prescription price

Avg: $423

NICHOLAOS BELLOS MD

Infectious Disease

3,005

$1.63M

152
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

23%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 48%

$541
Average prescription price

Avg: $423

MICHELLE ONORATO

Infectious Disease

2,868

$1.42M

131
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

24%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 48%

$497
Average prescription price

Avg: $423

BARBARA ATKINSON DO

Infectious Disease

2,850

$1.71M

114
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

19%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 48%

$598
Average prescription price

Avg: $423

GREGORY ANSTEAD MD

Infectious Disease

2,746

$1.32M

86
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

44%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 48%

$480
Average prescription price

Avg: $423

ROBERT ZAJAC MD

Infectious Disease

2,599

$1M

250
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 48%

$385
Average prescription price

Avg: $423

MUHAMMAD AKBAR M.D.

Infectious Disease

2,510

$965K

99
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 48%

$384
Average prescription price

Avg: $423

STEVEN HICKERSON M.D.

Infectious Disease

2,438

$1.36M

139
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 48%

$556
Average prescription price

Avg: $423

MAN LAM MD

Infectious Disease

2,342

$657K

197
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 48%

$281
Average prescription price

Avg: $423

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank